Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive Bladder
Clinical trial NCT00454740 · COMPLETED
Trial details
- NCT number
- NCT00454740
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Primary completion
- 2005-08-01
- Enrollment
- 441
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.